|
'Exvading' Invasive Pediatric Brain Tumors
|
5R01CA153229-02
|
$245,672
|
Bellamkonda, Ravi
|
GEORGIA INSTITUTE OF TECHNOLOGY
|
|
A Phase II Trial of Sunitinib in the Treatment of Recurrent Malignant Gliomas
|
ZIA BC 011367
|
$14,799
|
Kreisl, Teri
|
CCR (NCI)
|
|
A pilot study of statin therapy and risk of malignant glioma
|
5K07CA127468-04
|
$135,513
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
A PTEN-regulated ubiquitin switch controlling TRAIL sensitivity in GBM
|
5R01CA136774-03
|
$310,970
|
Pieper, Russell
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
A Role for PML in Genome Stability and DNA Damage Response
|
5R01CA055577-18
|
$256,139
|
CHANG, KUN-SANG
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
A20 Promotes Glioma Stem Cell Mediated Tumorigenesis
|
5R01CA151522-02
|
$252,801
|
Hjelmeland, Anita
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$1,178,242
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-35
|
$7,696,742
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-35S1
|
$50,000
|
LERMAN, CARYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
ADAM 17 and glioma-tumor progression and treatment
|
5R01CA129446-03
|
$291,849
|
JIANG, FENG
|
HENRY FORD HEALTH SYSTEM
|
|
Adoptive Immunotherapy for GBM During Hematopoietic Recovery from Temozolomide
|
5R01CA134844-03
|
$312,186
|
MITCHELL, DUANE
|
DUKE UNIVERSITY
|
|
Adoptive Transfer of AlloCTL for Immunotherapy of Recurrent Gliomas
|
7R01CA125244-02
|
$690,480
|
KRUSE, CAROL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Adult Brain Tumor Consortium (ABTC)
|
5U01CA137443-03
|
$1,905,232
|
GROSSMAN, STUART
|
JOHNS HOPKINS UNIVERSITY
|
|
Adult Neurobehavioral Late Effects of Pediatric Low Grade Brain Tumors
|
5R01CA132899-03
|
$340,627
|
Ris, M
|
BAYLOR COLLEGE OF MEDICINE
|
|
Advanced Training in Surgical Oncology
|
2T32CA009535-24A2
|
$161,835
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
AEG-1: Novel Gene Involved in Malignant Glioma
|
5R01CA134721-03
|
$300,907
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
AGAP2 regulates membrane trafficking and migaration of glioblastoma cells
|
5K22CA124578-03
|
$192,024
|
Nie, Zhongzhen
|
UNIVERSITY OF FLORIDA
|
|
Aging and Primary Central Nervous System Tumors
|
ZIA BC 011348
|
$43,803
|
Iwamoto, Fabio
|
CCR (NCI)
|
|
Akt-EphA2 Crosstalk in Glioma Invasion
|
5R01CA152371-02
|
$316,002
|
WANG, BINGCHENG
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
|
5R01CA122163-04
|
$504,006
|
SCHWARTZBAUM, JUDITH
|
OHIO STATE UNIVERSITY
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
5R01CA114205-06
|
$403,962
|
MICHAUD, DOMINIQUE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
ZIA BC 010709
|
$138,319
|
Warren, Katherine
|
CCR (NCI)
|
|
An Integrated CT-based Image-Guided Neurosurgical System
|
2R44CA112966-02A1
|
$648,549
|
VanKampen, William
|
XORAN TECHNOLOGIES, INC.
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
5R01CA129541-05
|
$309,624
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Analysis of active and inactive EGFR conformations
|
2R01CA112552-06A1
|
$234,554
|
FERGUSON, KATHRYN
|
UNIVERSITY OF PENNSYLVANIA
|
|
Analysis of the p53 in vivo using a unique mouse model
|
5R01CA100193-09
|
$334,263
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Apical-basal polarity signaling in glioblastoma
|
5R01CA149258-02
|
$310,465
|
Ghosh, Sourav
|
UNIVERSITY OF ARIZONA
|
|
Apparatus and Method for Convection Enhanced Therapeutic Delivery
|
1R43CA150521-01A1
|
$105,832
|
MARGOLIN, LEE
|
FHC, INC.
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S1
|
$139,575
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-33S2
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-33
|
$3,953,813
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Astatine And Iodine Radiolabeled Monoclonal Antibodies
|
5R01CA042324-25
|
$476,220
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
ATBC Study
|
ZIA CP010195-03031
|
$828,679
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
5U10CA045450-25
|
$482,599
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
Automatic Three Dimensional (3D) Registration for Enhanced Cancer Management
|
5P01CA087634-08
|
$1,382,595
|
Meyer, Charles
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Autophagy in Brain Tumor
|
5R01CA135038-03
|
$323,791
|
YANG, JIN-MING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Autoregressive Joinpoint Analysis of Cancer Trend Data
|
5R03CA141488-02
|
$70,810
|
Kim, Hyune-Ju
|
SYRACUSE UNIVERSITY
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
5R01CA129371-05
|
$607,551
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-22
|
$406,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-05S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-05
|
$2,934,758
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-10S1
|
$140,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-10
|
$882,302
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Behavioral Science Core
|
ZIC BC 011288
|
$746,710
|
Wayne, Alan
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$891,092
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$195,669
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers of survival in glioma epidemiology
|
5R01CA126831-04
|
$400,461
|
Wiencke, John
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Boronated nucleosides for neutron capture therapy of brain tumors
|
5R01CA127935-03
|
$249,684
|
TJARKS, WERNER
|
OHIO STATE UNIVERSITY
|
|
Brain cancer in Eastern Nebraska case-control study
|
ZIA CP010119-02210
|
$1,219
|
Ward, Mary
|
DCEG (NCI)
|
|
Brain Endothelial TNF-R1 Can Function to Inhibit Angiogenesis
|
5R01CA152883-02
|
$355,503
|
Gladson, Candece
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|